BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37145070)

  • 1. Detection of Plasma Antibodies Against CD25-Derived Peptide Antigens in Bladder Cancer.
    Du KL; Ji WT; Jiang QH; Wang Y
    Clin Lab; 2023 May; 69(5):. PubMed ID: 37145070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of Circulating Natural Antibodies Against CD25 and FOXP3 in Type-2 Diabetes.
    Qiu C; Li C; Wu X; Chen X; Zhang X; Meng Q
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
    Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
    Wang J; Xu Y; Wang Y; Zhang X; Zhang G
    Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
    Wang J; Xu Y; Zhao H; Zhang X
    J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of circulating anti-CD25 antibodies in non-small cell lung cancer.
    Ye L; Li X; Sun S; Guan S; Wang M; Guan X; Lee KH; Wei J; Liu B
    Clin Transl Oncol; 2013 Aug; 15(8):633-7. PubMed ID: 23263913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
    Liu S; Zhang X; Jiang Q; Liang T
    FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
    Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
    Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Levels of Circulating Anti-ANXA1 IgG Antibody in Patients with Non-Small Cell Lung Cancer.
    Liang T; Han Z; Zhao H; Zhang X; Wang Y
    Clin Lab; 2018 Jun; 64(6):895-900. PubMed ID: 29945332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma.
    Xu Y; Gu L; Wang J; Wang Z; Zhang P; Zhang X
    Lab Med; 2020 Nov; 51(6):574-578. PubMed ID: 32195537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
    Wang W; Guan S; Sun S; Jin Y; Lee KH; Chen Y; Wei J
    Tumour Biol; 2014 May; 35(5):4901-5. PubMed ID: 24453033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
    Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
    Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population.
    Li C; Whelan R; Yang H; Jiang Y; Qiu C; Meng Q; Wei J
    FEBS Open Bio; 2019 Oct; 9(10):1705-1712. PubMed ID: 31336035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further analysis of natural antibodies against ischemic stroke.
    Qi J; Jiang Q; Wang P; Wang Z; Zhang X
    Front Neurol; 2023; 14():1130748. PubMed ID: 36741286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Molecular Serology of Human
    Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Lee DE; Kaltenboeck B
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of circulating antibodies to ANXA1 in breast cancer.
    Huang Y; Zhang C; Chen C; Sun S; Zheng H; Wan S; Meng Q; Chen Y; Wei J
    Tumour Biol; 2015 Feb; 36(2):1233-6. PubMed ID: 25344217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of type-1 diabetes associated autoantibodies in schizophrenia.
    Hallford P; Clair DS; Halley L; Mustard C; Wei J
    Schizophr Res; 2016 Oct; 176(2-3):186-190. PubMed ID: 27474348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating antibodies to p16 protein-derived peptides in breast cancer.
    Chen C; Huang Y; Zhang C; Liu T; Zheng HE; Wan S; Sun S; Meng Q; Chen Y; Wei J
    Mol Clin Oncol; 2015 May; 3(3):591-594. PubMed ID: 26137272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Wang Y
    FEBS Open Bio; 2018 Nov; 8(11):1875-1881. PubMed ID: 30410866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.